研究業績

一般社団法人JBCRG学会発表

2012年


JBCRG10年のあゆみと展望


黒井克昌


広島大学医学部 広仁会館2階 大会議室

Inter-observer concordance of Ki-67 labeling index inbreast cancer[br]: Japan Breast Cancer Research Group (JBCRG) Ki-67 Ring Study


T Ueno, Y Mikami, K Yoshimura, H Tsuda, M Kurosumi, S Masuda, R Horii, M Toi, and H Sasano


2012 SABCS Poster Session 5

A Prospective Multicenter Randomized Phase II Neo-Adjuvant Study of 5-Fluorouracil, Epirubicin and Cyclophosphamide (FEC) Followed by Docetaxel, Cyclophosphamide and Trastuzumab (TCH) Versus TCH Followed by FEC Versus TCH Alone, in Patients (pts) with Operable HER2 Positive Breast Cancer: JBCRG-10 Study


Masuda N, Sato N, Higaki K, Kashiwaba M, Matsunami N, Takano T, Yamamura J, Kaneko K, Takahashi M, Ohno S, Fujisawa T, Tsuyuki S, Miyoshi Y, Ohtani S, Yamamoto Y, Bando H, Onoda T, Kawabata H, Morita S, Ueno T, Toi M


2012 SABCS Poster Session 1

任意団体JBCRG 研究業績